<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>28(2)</volume><submitter>Camard L</submitter><funding>Foundation for Medical Research</funding><funding>J&amp;amp;J Innovative Medicine</funding><funding>Institut Pasteur</funding><pubmed_abstract>IL-23 signaling plays a key role in the pathogenesis of chronic inflammatory and infectious diseases, yet the cellular targets and signaling pathways affected by this cytokine remain poorly understood. We show that IL-23 receptors are expressed on the large majority of human mucosal-associated invariant T (MAIT), but not of conventional T cells. Protein and transcriptional profiling at the population and single cell level demonstrates that stimulation with IL-23 or the structurally related cytokine IL-12 drives distinct functional profiles, revealing a high level of plasticity of MAIT cells. IL-23, in particular, affects key molecules and pathways related to autoimmunity and cytotoxic functions. Integrated analysis of transcriptomes and chromatin accessibility, supported by CRISPR-Cas9 med</pubmed_abstract><journal>iScience</journal><pagination>111898</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11850163</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>IL-23 tunes inflammatory functions of human mucosal-associated invariant T cells.</pubmed_title><pmcid>PMC11850163</pmcid><pubmed_authors>Yahia-Cherbal H</pubmed_authors><pubmed_authors>Cua DJ</pubmed_authors><pubmed_authors>Camard L</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Stephen T</pubmed_authors><pubmed_authors>Pietrosemoli N</pubmed_authors><pubmed_authors>Leloup C</pubmed_authors><pubmed_authors>Cantini L</pubmed_authors><pubmed_authors>Hasan M</pubmed_authors><pubmed_authors>Baillet V</pubmed_authors><pubmed_authors>Parker R</pubmed_authors><pubmed_authors>Bianchi E</pubmed_authors><pubmed_authors>Mella S</pubmed_authors><pubmed_authors>Guillemot V</pubmed_authors><pubmed_authors>Greving C</pubmed_authors><pubmed_authors>Joyce-Shaikh B</pubmed_authors><pubmed_authors>Lopez-Maestre H</pubmed_authors><pubmed_authors>Rogge L</pubmed_authors><pubmed_authors>Capocefalo D</pubmed_authors><pubmed_authors>Eckle SBG</pubmed_authors><pubmed_authors>Marsande J</pubmed_authors><pubmed_authors>Dangien A</pubmed_authors><pubmed_authors>Fourie AM</pubmed_authors><pubmed_authors>Garro K</pubmed_authors><pubmed_authors>Sienes Bailo J</pubmed_authors></additional><is_claimable>false</is_claimable><name>IL-23 tunes inflammatory functions of human mucosal-associated invariant T cells.</name><description>IL-23 signaling plays a key role in the pathogenesis of chronic inflammatory and infectious diseases, yet the cellular targets and signaling pathways affected by this cytokine remain poorly understood. We show that IL-23 receptors are expressed on the large majority of human mucosal-associated invariant T (MAIT), but not of conventional T cells. Protein and transcriptional profiling at the population and single cell level demonstrates that stimulation with IL-23 or the structurally related cytokine IL-12 drives distinct functional profiles, revealing a high level of plasticity of MAIT cells. IL-23, in particular, affects key molecules and pathways related to autoimmunity and cytotoxic functions. Integrated analysis of transcriptomes and chromatin accessibility, supported by CRISPR-Cas9 med</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Feb</publication><modification>2026-06-01T21:16:04.342Z</modification><creation>2025-04-06T10:34:18.397Z</creation></dates><accession>S-EPMC11850163</accession><cross_references><pubmed>40008359</pubmed><doi>10.1016/j.isci.2025.111898</doi></cross_references></HashMap>